Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness and Safety of COVID-19 Vaccine in Patients With Inflammatory Bowel Disease Treated With Immunomodulatory or Biological Drugs

NCT04769258 is registered in ClinicalTrials.gov with Italian Group for the study of Inflammatory Bowel Disease (IG-IBD) as lead sponsor.

NCT NCT04769258
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04769258 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness and Safety of COVID-19 Vaccine in Patients With Inflammatory Bowel Disease Treated With Immunomodulatory or Biological Drugs
Lead sponsor
Italian Group for the study of Inflammatory Bowel Disease (IG-IBD)
Phase
Observational
Overall status
Unknown status
Start date
March 1, 2021
Completion date
June 1, 2022
Enrollment
1,380 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

inflammatory bowel diseases